World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 18 March 2024
Main ID:  NCT01753011
Date of registration: 17/12/2012
Prospective Registration: No
Primary sponsor: Cantonal Hospital, Frauenfeld
Public title: Urethral Length and TOT (Transobturator Tape) Positioning
Scientific title: Prospective, Observational Study: Can Pelvic Floor Ultrasound Help to Optimize TOT (Transobturator Tape) Positioning?
Date of first enrolment: May 2007
Target sample size: 123
Recruitment status: Completed
URL:  https://clinicaltrials.gov/ct2/show/NCT01753011
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
Germany Switzerland
Contacts
Name:     Volker Viereck, Prof. Dr.
Address: 
Telephone:
Email:
Affiliation:  Cantonal Hospital, Frauenfeld
Key inclusion & exclusion criteria

Inclusion Criteria:

1. Patient has objective demonstrable signs of stress urinary incontinence (SUI),
including patients with intrinsic sphincter deficiency (ISD). Objective testing
includes: standing stress test, urodynamics evaluation, or pad test.

2. Patient is age 18 or older.

3. Patient agrees to participate in the study, including completion of all study-related
procedures and evaluations, and documents this agreement by signing the Institutional
Review Board (IRB)/Ethic commission (EC)-approved informed consent.

4. Patient is able to fill in all questionnaires (on judgement of investigator)

Exclusion Criteria:

1. Patient has an associated or suspected neurological disease.

2. Patient has an active lesion or present injury to perineum or urethra.

3. Patient has a urethral obstruction.

4. Patient has significant pelvic organ prolapse (Grade III/IV) requiring surgical
treatment.

5. Patient currently has an urinary tract infection.



Age minimum: 18 Years
Age maximum: 99 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Stress Urinary Incontinence
Intervention(s)
Primary Outcome(s)
Cure rate [Time Frame: 6 months postoperative]
Secondary Outcome(s)
Urethral tape position [Time Frame: 1-3 days and 6 months postoperative]
Distance between tape and longitudinal smooth muscle (LSM) complex [Time Frame: 1-3 days and 6 months postoperative]
Urodynamic testing [Time Frame: Preoperative]
Linear urethral dorsocaudal movement (LUDM) [Time Frame: Preoperative]
Urethral length [Time Frame: Preoperative]
Secondary ID(s)
TOT 1/2-Rule
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history